These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31479509)

  • 1. Low rates of diagnostic colonoscopy in Federally Qualified Health Centers: A persistent problem that must be addressed to achieve the promise of colorectal cancer screening.
    Myers RE
    Cancer; 2019 Dec; 125(23):4134-4135. PubMed ID: 31479509
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
    Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
    Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Colorectal Cancer Screening in Federally Qualified Health Centers.
    Riehman KS; Stephens RL; Henry-Tanner J; Brooks D
    Am J Prev Med; 2018 Feb; 54(2):190-196. PubMed ID: 29198834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.
    Shareef F; Bharti B; Garcia-Bigley F; Hernandez M; Nodora J; Liu J; Ramers C; Nery JD; Marquez J; Moyano K; Rojas S; Arredondo E; Gupta S
    J Prim Care Community Health; 2024; 15():21501319241242571. PubMed ID: 38554066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
    Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
    J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers.
    Petrik AF; Le T; Keast E; Rivelli J; Bigler K; Green B; Vollmer WM; Coronado G
    J Community Health; 2018 Feb; 43(1):128-136. PubMed ID: 28744716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
    Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
    Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
    Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
    Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
    Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Effectiveness of Provider Incentives to Increase CRC Screening Uptake in Neighborhood Healthcare: A California Federally Qualified Health Center.
    Barajas M; Tangka FKL; Schultz J; Tantod K; Kempster YM; Omelu N; Hoover S; Thomas M; Richmond-Reese V; Subramanian S
    Health Promot Pract; 2020 Nov; 21(6):898-904. PubMed ID: 32990046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.